Approval · Notice of Compliance 11241 · 2010
CELSENTRI: Notice of Compliance 11241
Issued April 9, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11241
- Date
- April 9, 2010
- Company
- Viiv Healthcare UlcMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: Use in treatment-naive patients infected with CCR5-tropic HIV-1
- Therapeutic class
- CCR5 antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CELSENTRI | Not yet assigned | — |